Oxford and GSK launch £50million immuno-prevention programme to advance novel cancer research

Published on January 27, 2025

Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.